Atrial Fibrillation

AFib Might Be Far More Common Than We Think

A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease.

UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg. age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib.

  • AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019.
  • That increase was greatest among younger patients, males, minorities, and patients with hypertension and diabetes. 

When these results are applied across the U.S., the researchers estimate that at least 10.55M Americans are currently diagnosed with AFib, representing 4.48% the U.S. adult population.

  • That’s far higher than previous estimates, including a pair of JAMA and Circulation studies that estimated nationwide AFib rates of 2.26M and 5.1M back in 2000, and forecasted that 3.33M and 7.5M adults would have AFib by 2020.

Since all of these studies only looked at patients who were already diagnosed, true AFib prevalence is likely far higher, with the authors noting that wearable-based arrhythmia detection might drive far more significant diagnosis increases in the future.

The Takeaway

Although few readers are likely surprised that AFib diagnosis is on the rise, this study’s 51% growth rate and 4.48% prevalence estimate truly are shocking, and suggest that we might see a wave of AFib-related care in the future.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology August 28, 2025

Cardiologists, Practice What You Preach! August 28, 2025

Cardiologists might be struggling with the same lifestyle challenges they counsel patients about, as a national survey of ACC members revealed significant gaps between what physicians’ recommend and how they act. The ACC CardioSurve study surveyed 166 U.S. cardiologists about their training in lifestyle medicine and clinical recommendations across all six lifestyle pillars, revealing some […]

Obesity Care August 25, 2025

GLP-1s Work, But Not for Free August 25, 2025

Real-world semaglutide (Wegovy) patients might be experiencing a healthcare cost paradox, after a recent analysis in JAMA showed that GLP-1s successfully reduce weight and improve cardiovascular risk factors, but lead to increased patient healthcare expenditures in the short term. The real-world analysis examined 23.5k adults prescribed semaglutide between January 2018 and January 2025 across two […]

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

This content is exclusive to subscribers

Log in or join by entering your email below.

Completely free. Every Monday and Thursday.

CW Phone Square

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!